Recombinant Human Anti-BRLF1 Soluble TCR (AG5) (C-Cys) (CAT#: VS-0622-YF3806)

Human TCR (AG5) recognizes BRLF1 peptide (YVLDHLIVV) in the context of HLA-A*02:01. Soluble TCR is expressed with C-terminal Cys strategy (TRAV-TRAC partial-Cys, TRBV-TRBC partial-Cys). Depending the C-terminal Cys, two chains form heterodimer. Please note that the activity is not guaranteed.

Specific Inquiry
  • Size:
  • Conjugation:
  • Datasheet
  • MSDS
  • COA

Specifications

  • Host Species
  • Human
  • Target
  • BRLF1
  • Species Reactivity
  • EBV4
  • Epitope
  • YVLDHLIVV
  • MHC
  • HLA-A*02:01
  • Clone
  • AG5
  • Type
  • Soluble TCR (C-Cys)
  • Related Disease
  • Pancreatic cancer
  • TCR Expression Strategy
  • C-Cys strategy: the alpha and beta chain (without transmembrane and cytosolic region) can form heterodimer based on C-terminal Cys. The soluble TCR contains variable regions and partial constant regions.

Target

  • Alternative Names
  • HHV4_BRLF1

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Clone AG5"

See other products for "BRLF1"

Select a product category from the dropdown menu below to view related products.
Please select product type
MHC Tetramer Products for Virology

Customer Reviews and Q&As

Submit a review or a question

There are currently no Customer reviews or questions for VS-0622-YF3806. Click the button above to contact us or submit your feedback about this product.

Popular products with customers


For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

  • 0
  • 0
Cart
    Go to compare

    Go to compare